Psychological distress and coping strategies in patients with psoriasis: The PSYCHAE Study

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 9, 2007, Pages 1161-1169

  Finzi, Aldo ^a,ah   Colombo, D ^a   Caputo, A ^a   Andreassi, L ^b   Chimenti, S ^c   Vena, G ^d   Simoni, L ^e   Sgarbi, S ^f   Giannetti, A ^f   Bianchi, ^g   Gallo, ^a,h,ae   Baldo, ⁱ   Flori, ^b   Zane, ^j   Di Nuzzo, ^k   Catteneo, ^a   Altiero, ^l   Lo Schiavo, ⁱ   Kokelj, ^m   Masci, ⁿ   Locatelli, ^o   Bardazzi, ^p   Coppini, ^a   Reseghetti, ^q   Amato, ^r   Lacarrubba, ^s   Manfre ^t   Cavallaro, ^u   Soro, ^v   Schena, ^d   Vena, ^w   Montesu, ^u   Bonvicino, ^x   Zucca, ^y   Garcovich, ^z   Bongiorno, ^aa   Giuliano, ^ab   Zavattaro, ^a   Rossini, ^d   Loconsole, ^ac   Simonetti, ^ad   Favot, ^af   Repetto, ^q   Difonzo, ^ad   Calvieri, ^ag   Cecchetti, ^ac   more..

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e MediData Studi e Ricerche   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g UNIVERSITY OF ROME TOR VERGATA   (Italy)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^j UNIVERSITY OF BRESCIA   (Italy)

^k UNIVERSITY OF PARMA   (Italy)

^l UNIVERSITY OF FERRARA   (Italy)

^m UNIVERSITY OF TRIESTE   (Italy)

ⁿ UNIVERSITY OF CHIETI   (Italy)

^o UNIVERSITY OF BOLOGNA   (Italy)

^p UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^q UNIVERSITY OF FLORENCE   (Italy)

^r UNIVERSITY OF CATANIA   (Italy)

^s UNIVERSITY OF MESSINA   (Italy)

^t UNIVERSITY OF L'AQUILA   (Italy)

^u UNIVERSITY OF TURIN   (Italy)

^v UNIVERSITY OF VERONA   (Italy)

^w UNIVERSITY OF SASSARI   (Italy)

^x UNIVERSITY OF CAGLIARI   (Italy)

^y CATHOLIC UNIVERSITY   (Italy)

^z UNIVERSITY OF PALERMO   (Italy)

^aa UNIVERSITY OF PISA   (Italy)

^ab UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^ac UNIVERSITY OF PERUGIA   (Italy)

^ad SAPIENZA UNIVERSITY OF ROME   (Italy)

^ae UNIVERSITY OF UDINE   (Italy)

^af UNIVERSITY OF GENOA   (Italy)

^ag UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^ah University of Pisa Barachini ^*  (Italy)

more..

Author keywords

Coping; Epidemiology; Psoriasis; Psychological distress

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; BODY SURFACE; BRIEF SYMPTOM INVENTORY; CLINICAL EVALUATION; COPING BEHAVIOR; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; GENERAL HEALTH QUESTIONNAIRE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PATIENT CARE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PSORIASIS; SEX DIFFERENCE;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; PSORIASIS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STRESS, PSYCHOLOGICAL;

EID: 34548708464     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02079.x     Document Type: Article

References (54)

1. Fortune DG, Richards HL, Griffiths CE. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin 2005; 23: 681-694.
2. Ginsburg IH. Psychological and psychophysiological aspects of psoriasis. Dermatol Clin 1995; 13: 793-804.
3. Fortune DG, Richards HL, Griffiths CE, Main CJ. Psychological stress, distress and disability in patients with psoriasis: Consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002; 41: 157-174.
4. Leary MR, Rapp SR, Herbst KC, Exum ML, Feldman SR. Interpersonal concerns and psychological difficulties of psoriasis patients: Effects of disease severity and fear of negative evaluation. Health Psychol 1998; 17: 530-536.
5. Fortune DG, Richards HL, Main CJ, Griffiths CE. Patients' strategies for coping with psoriasis. Clin Exp Dermatol 2002; 27: 177-184.
6. Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: Epidemiology and management. Am J Clin Dermatol 2003; 4: 833-842.
7. Russo PA, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: A review. Australas J Dermatol 2004; 45: 155-159; quiz 160-1.
8. Kirby B, Richards HL, Woo P, Hindle E, Main CJ, Griffiths CE. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001; 45: 72-76.
9. Richards HL, Fortune DG, O'Sullivan TM, Main CJ, Griffiths CE. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 1999; 41: 581-583.
10. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: An issue to be recognized. Br J Dermatol 2000; 143: 983-991.
11. Picardi A, Abeni D, Renzi C, Braga M, Puddu P, Pasquini P. Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Derm Venereol 2001; 81: 410-414.
12. Akay A, Pekcanlar A, Bozdag KE, Altintas L, Karaman A. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol 2002; 16: 347-352.
13. Richards HL, Fortune DG, Griffiths CE, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001; 50: 11-15.
14. Devrimci-Ozguven H, Kundakci TN, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000; 14: 267-271.
15. Bharath S, Shamasundar C, Raghuram R, Subbakrishna DK. Psychiatric morbidity in leprosy and psoriasis - a comparative study. Indian J Lepr 1997; 69: 341-346.
16. Sharma N, Koranne RV, Singh RK. Psychiatric morbidity in psoriasis and vitiligo: A comparative study. J Dermatol 2001; 28: 419-423.
17. Calikoglu E, Onder M, Cosar B, Candansayar S. Depression, anxiety levels and general psychological profile in Behçet's disease. Dermatology 2001; 203: 238-240.
18. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846-850.
19. Scharloo M, Kaptein AA, Weinman J, Bergman W, Vermeer BJ, Rooijmans HG. Patients' illness perceptions and coping as predictors of functional status in psoriasis: A 1-year follow-up. Br J Dermatol 2000; 142: 899-907.
20. Niemeier V, Nippesen M, Kupfer J, Schill WB, Gieler U. Psychological factors associated with hand dermatoses: Which subgroup needs additional psychological care? Br J Dermatol 2002; 146: 1031-1037.
21. Gupta MA, Gupta AK, Watteel GN. Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: An index of the stigma experience in dermatologic disorders. Cutis 1998; 61: 339-342.
22. Kent G, Keohane S. Social anxiety and disfigurement: The moderating effects of fear of negative evaluation and past experience. Br J Clin Psychol 2001; 40: 23-34.
23. Fortune DG, Richards HL, Kirby B, McElhone K, Main CJ, Griffiths CE. Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being. Br J Dermatol 2004; 151: 1219-1226.
24. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Assessing illness-related stress in psoriasis: The psychometric properties of the Psoriasis Life Stress Inventory. J Psychosom Res 1997; 42: 467-475.
25. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137: 755-760.
26. Fortune DG, Richards HL, Griffiths CE, Main CJ. Targeting cognitive-behaviour therapy to patients. implicit model of psoriasis: results from a patient preference controlled trial. Br J Clin Psychol 2004; 43: 65-82.
27. Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-407.
28. Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol 2002; 147: 736-742.
29. Wahl AK, Gjengedal E, Hanestad BR. The bodily suffering of living with severe psoriasis: In-depth interviews with 22 hospitalized patients with psoriasis. Qual Health Res 2002; 12: 250-261.
30. de Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC. Psoriasis of the nails associated with disability in a large number of patients: Results of a recent interview with 1,728 patients. Dermatology 1996; 193: 300-303.
31. Pettey AA, Balkrishnan R, Rapp SR, Fleischer AB, Feldman SR. Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: Implications for clinical practice. J Am Acad Dermatol 2003; 49: 271-275.
32. Zachariae H, Zachariae R, Blomqvist K et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol 2002; 82: 108-113.
33. Zachariae R, Zachariae H, Blomqvist K et al. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol 2002; 146: 1006-1016.
34. Gupta MA, Gupta AK. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol 1995; 34: 700-703.
35. Mazzotti E, Picardi A, Sampogna F et al. Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis. Br J Dermatol 2003; 149: 318-322.
36. Perrott SB, Murray AH, Lowe J, Mathieson CM. The psychosocial impact of psoriasis: Physical severity, quality of life, and stigmatization. Physiol Behav 2000; 70: 567-571.
37. Gupta G, Long J, Tillman DM. The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures. Br J Dermatol 1999; 140: 887-890.
38. Lebwohl M, Christophers E, Langley R et al. An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol 2003; 139: 719-727.
39. Salek MS, Finlay AY, Lewis JJ, Sumner MI. Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral). Qual Life Res 2004; 13: 91-95.
40. Touw CR, Hakkaart-Van Roijen L, Verboom P, Paul C, Rutten FF, Finlay AY. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001; 144: 967-972.
41. Gupta MA, Gupta AK, Haberman HF. Psoriasis and psychiatry: An update. Gen Hosp Psychiatry 1987; 9: 157-166.
42. Picardi A, Amerio P, Baliva G et al. Recognition of depressive and anxiety disorders in dermatological outpatients. Acta Derm Venereol 2004; 84: 213-217.
43. Richards HL, Fortune DG, Weidmann A, Sweeney SK, Griffiths CE. Detection of psychological distress in patients with psoriasis: Low consensus between dermatologist and patient. Br J Dermatol 2004; 151: 1227-1233.
44. Picardi A, Abeni D, Mazzotti E et al. Screening for psychiatric disorders in patients with skin diseases: A performance study of the 12-item General Health Questionnaire. J Psychosom Res 2004; 57: 219-223.
45. Picardi A, Abeni D, Pasquini P. Assessing psychological distress in patients with skin diseases: Reliability, validity and factor structure of the GHQ-12. J Eur Acad Dermatol Venereol 2001; 15: 410-417.
46. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: An introductory report. Psychol Med 1983; 13: 595-605.
47. Piersma HL, Reaume WM, Boes JL. The Brief Symptom Inventory (BSI) as an outcome measure for adult psychiatric inpatients. J Clin Psychol 1994; 50: 555-563.
48. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med 1997; 4: 92-100.
49. Aktan S, Ozmen E, Sanli B. Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology 1998; 197: 230-234.
50. Calderwood L, Park A. Chapter 11 - General Health. The Scottish Health Survey 1998: 2000.
51. Hughes JE, Barraclough BM, Hamblin LG, White JE. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983; 143: 51-54.
52. Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 2005; 210: 194-199.
53. Finlay AY. Current severe psoriasis and the rule of ten. Br J Dermatol 2005:861-887.
54. McKenna KE, Stern RE. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol 1996:534-538.